Tumor microenvironment gene expression profiles associated to complete pathological response and disease progression in resectable NSCLC patients treated with neoadjuvant chemoimmu...

por Casarrubios, Marta, Provencio, Mariano, Nadal, Ernest, Insa, Amelia, del Rosario García-Campelo, María, Lázaro-Quintela, Martín, Dómine, Manuel, Majem, Margarita, Rodriguez-Abreu, Delvys, Martinez-Marti, Alex, De Castro Carpeño, Javier, Cobo, Manuel, López Vivanco, Guillermo, Del Barco, Edel, Bernabé, Reyes, Viñolas, Nuria, Barneto Aranda, Isidoro, Massuti, Bartomeu, Sierra-Rodero, Belén, Martinez-Toledo, Cristina, Fernández-Miranda, Ismael, Serna-Blanco, Roberto, Romero, Atocha, Calvo, Virginia, Cruz-Bermúdez, Alberto
Publicado 2022

First-line nivolumab plus ipilimumab for metastatic non-small cell lung cancer, including patients with ECOG performance status 2 and other special populations: CheckMate 817

por Ready, Neal E, Audigier-Valette, Clarisse, Goldman, Jonathan W, Felip, Enriqueta, Ciuleanu, Tudor-Eliade, Rosario García Campelo, María, Jao, Kevin, Barlesi, Fabrice, Bordenave, Stéphanie, Rijavec, Erika, Urban, Laszlo, Aucoin, Jean-Sébastien, Zannori, Cristina, Vermaelen, Karim, Arén Frontera, Osvaldo, Curioni Fontecedro, Alessandra, Sánchez-Gastaldo, Amparo, Juan-Vidal, Oscar, Linardou, Helena, Poddubskaya, Elena, Spigel, David R, Ahmed, Samreen, Maio, Michele, Li, Sunney, Chang, Han, Fiore, Joseph, Acevedo, Angelic, Paz-Ares, Luis
Publicado 2023